Trial Profile
A retrospective, multicentre observational study to evaluate the efficacy of eribulin mesylate with taxane regimens (including combination with bevacizumab) in patients with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Eribulin (Primary) ; Bevacizumab; Docetaxel; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Feb 2016 New trial record